Iradimed Corp financial data

Symbol
IRMD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1025 Willa Springs Dr., Winter Springs, FL
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 747 % -23.1%
Quick Ratio 125 % +41%
Debt-to-equity 18.5 % +12.8%
Return On Equity 24.7 % +16.4%
Return On Assets 20.9 % +14.4%
Operating Margin 30.9 % +6.45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.7M shares +0.53%
Common Stock, Shares, Outstanding 12.7M shares
Entity Public Float 379M USD +56.1%
Common Stock, Value, Issued 1.27K USD +0.56%
Weighted Average Number of Shares Outstanding, Basic 12.7M shares +0.55%
Weighted Average Number of Shares Outstanding, Diluted 12.8M shares +0.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 69.5M USD +16%
Revenue from Contract with Customer, Excluding Assessed Tax 69.5M USD +16%
Cost of Revenue 15.8M USD +11.5%
Research and Development Expense 3.53M USD -30.3%
Selling and Marketing Expense 12.7M USD +21.6%
General and Administrative Expense 16M USD +24.8%
Operating Income (Loss) 21.4M USD +23.5%
Nonoperating Income (Expense) 2.16M USD +75.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 23.6M USD +27%
Income Tax Expense (Benefit) 4.96M USD +27.1%
Net Income (Loss) Attributable to Parent 18.6M USD +27%
Earnings Per Share, Basic 1.48 USD/shares +27.6%
Earnings Per Share, Diluted 1.45 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.5M USD +5.92%
Accounts Receivable, after Allowance for Credit Loss, Current 12M USD +7.86%
Inventory, Net 12.1M USD +43.4%
Assets, Current 73.6M USD +11.3%
Deferred Income Tax Assets, Net 2.59M USD +46.7%
Property, Plant and Equipment, Net 10.5M USD +20.1%
Operating Lease, Right-of-Use Asset 372K USD -83.5%
Other Assets, Noncurrent 188K USD -25.4%
Assets 89.9M USD +10.5%
Accounts Payable, Current 1.12M USD -56.1%
Employee-related Liabilities, Current 2.9M USD +24.5%
Contract with Customer, Liability, Current 2.54M USD +48%
Liabilities, Current 7.46M USD -1.68%
Contract with Customer, Liability, Noncurrent 2.82M USD -6.57%
Operating Lease, Liability, Noncurrent 1.52M USD -21.6%
Liabilities 10.3M USD -17.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) 50.4M USD +21.1%
Stockholders' Equity Attributable to Parent 79.7M USD +15.5%
Liabilities and Equity 89.9M USD +10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.88M USD -16.4%
Net Cash Provided by (Used in) Financing Activities -8.04M USD +39.4%
Net Cash Provided by (Used in) Investing Activities -479K USD +92.7%
Common Stock, Shares Authorized 31.5M shares 0%
Common Stock, Shares, Issued 12.7M shares +0.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.64M USD +69.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.5M USD +5.92%
Operating Lease, Liability 372K USD -83.5%
Depreciation 142K USD -12.6%
Payments to Acquire Property, Plant, and Equipment 271K USD -95.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 17.2M USD +34.2%
Lessee, Operating Lease, Liability, to be Paid 460K USD -82.5%
Property, Plant and Equipment, Gross 14.8M USD +18.6%
Operating Lease, Liability, Current 368K USD -11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 411K USD -4.42%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.85K USD -99.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 88.6K USD -77.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 410K USD -0.34%
Lessee, Operating Lease, Liability, to be Paid, Year Four 410K USD 0%
Operating Lease, Payments 162K USD +26.3%
Additional Paid in Capital 29.3M USD +6.96%
Amortization of Intangible Assets 181K USD +79.7%
Depreciation, Depletion and Amortization 226K USD +23.9%
Share-based Payment Arrangement, Expense 2.32M USD +20.9%